eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2012
vol. 37
 
Share:
Share:
abstract:

Review paper
Cytokines and periodontitis. Part I: interleukin-1 and interleukin-1 receptor antagonist

Sylwia Małgorzata Słotwińska

(Centr Eur J Immunol 2012; 37 (2): 173-177)
Online publish date: 2012/05/22
View full text Get citation
 
Studies on periodontal disease pathogenesis are for years concentrating on elucidating the mechanism of immune reaction to endotoxins, exotoxins and other products of bacterial cell metabolism. The course and severity of periodontitis can be significantly affected by bacterial virulence as well as host immunity dysfunction. Periodontal tissue destruction has been proved to result from cascade of cytokines synthesized by reactive cells upon stimulation by pathogenic bacteria and lipopolysaccharides within their cell membranes. Trials are undertaken to inactivate interleukin-1 (IL-1) – the most active cytokine in the pathogenesis of periodontal disease. Much hope is placed in gene therapy, utilizing modified techniques of gene transfer into the target cells. The clinical use of genetically programmed cells, producing substances blocking IL-1, based on recombinant IL-1 antagonist, as well as cytokines activating fibroblasts and osteoblasts to regenerate the destroyed periodontal tissue could prove alternative to the conventional treatment.
keywords:

periodontitis, host response, interleukin-1, interleukin-1 receptor antagonist

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.